Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK‐788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy Volunteers

por Zhang, Steven, Jin, Shu, Griffin, Celina, Feng, Zhongling, Lin, Jianchang, Venkatakrishnan, Karthik, Gupta, Neeraj
Publicado 2021

Single‐Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK‐788) in Healthy Volunteers: Low‐Fat Meal Effect and Relative...

por Zhang, Steven, Jin, Shu, Griffin, Celina, Feng, Zhongling, Lin, Jianchang, Baratta, Mike, Brake, Rachael, Venkatakrishnan, Karthik, Gupta, Neeraj
Publicado 2021

Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer: A Phase 1/2 Open-label Non...

por Zhou, Caicun, Ramalingam, Suresh S., Kim, Tae Min, Kim, Sang-We, Yang, James Chih-Hsin, Riely, Gregory J., Mekhail, Tarek, Nguyen, Danny, Garcia Campelo, Maria R., Felip, Enriqueta, Vincent, Sylvie, Jin, Shu, Griffin, Celina, Bunn, Veronica, Lin, Jianchang, Lin, Huamao M., Mehta, Minal, Jänne, Pasi A.
Publicado 2021